A new artificial intelligence system developed by researchers at Wake Forest University School of Medicine could help clinicians detect several forms of heart dysfunction using a routine electrocardiogram (ECG), including heart failure with preserved ejection fraction (HFpEF), a condition that frequently escapes early diagnosis.
The University of Tennessee, Knoxville, has appointed radiopharmaceutical scientist Carolyn J. Anderson as a UT–Oak Ridge National Laboratory (ORNL) Governor’s Chair for Nuclear Medicine: Radiopharmaceutical Therapies.
A groundbreaking development in the treatment of triple-negative breast cancer (TNBC) is emerging from a collaborative research initiative involving the University of Houston and the University of Tennessee Health Science Center.
In a significant addition to the Pensacola, Florida medical community, Ochsner Novant Health 65 Plus – Bellview has announced the welcoming of Dr. Brandon M. McElroy, a board-certified internal medicine physician with close to a decade of expertise in primary care.
In a groundbreaking advance that heralds a new era in pediatric oncology, researchers at St. Jude Children’s Research Hospital have unveiled a promising therapeutic strategy to combat neuroblastoma, a devastating childhood cancer notorious for its complexity and resistance to treatment.
Dr. Jianyang Du, an accomplished associate professor at the University of Tennessee Health Science Center, has recently been awarded a notable grant of $1.5 million from the National Institute of Mental Health.
Researchers are continuously striving to unravel the complexities of human biology, and recent advancements have brought them closer to this goal.
Immunotherapy, treatments that reinvigorate immune cells’ anti-cancer activity or reprogram T cells to target cancer, has shown promise in treating leukemias but has not yet been realized in solid tumors.
